Current Diagnosis and Management of Immune Related Adverse Events (irAEs) Induced by Immune Checkpoint Inhibitor Therapy

• Main Authors: Vivek Kumar (Author), Neha Chaudhary (Author), Mohit Garg (Author), Charalampos S. Floudas (Author), Parita Soni (Author), Abhinav B. Chandra (Author)
• Format: Book
• Published: Frontiers Media S.A., 2017-02-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

The indications of immune checkpoint inhibitors (ICIs) are set to rise further with the approval of newer agent like atezolimumab for use in patients with advanced stage urothelial carcinoma. More frequent use of ICIs has improved our understanding of their unique side effects, which are known as im...